Clinical Trial: A Study of Roginolisib (IOA-244) in Combination with Dostarlimab with or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879717) titled 'A Study of Roginolisib (IOA-244) in Combination with Dostarlimab with or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients' on March 05.

Brief Summary: The goal of this clinical trial is to learn how roginolisib works in combination with dostarlimab with or without docetaxel in adult patients with advanced non small-cell lung cancer. The main questions it aims to answer are:

To compare across the treatment arms the proportion of patients with a reduction in Treg cells To evaluate the safety and tolerability of roginolisib plus dostarlimab, with or without docetaxel

Study Start Date: April, 2025

Study Ty...